Kazushige Nirei

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara et al. · The Lancet Infectious Diseases · 2015 · 361 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 <scp>HCV</scp> infection: an open‐label, phase 3 trial

Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno et al. · Journal of Viral Hepatitis · 2014 · 201 citations · Full text

Japanese Patients, Hcv Infection, Hepatology +13

Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis

Shunichi Matsuoka, Hiroshi Matsumura, Hitomi Nakamura et al. · Journal of Clinical Biochemistry and Nutrition · 2009 · 65 citations · Full text

Nutrition, Liver Cirrhosis, Pharmacotherapy +20

Influence of Occult Hepatitis B Virus Coinfection on the Incidence of Fibrosis and Hepatocellular Carcinoma in Chronic Hepatitis C

Shunichi Matsuoka, Kazushige Nirei, Akinori Tamura et al. · Intervirology · 2008 · 63 citations

Immunology, Hepatitis B, Pathology +20

Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis.

Shunichi Matsuoka, Hiroshi Matsumura, Hitomi Nakamura et al. · PubMed · 2009 · 63 citations · Full text

Nutrition, Liver Cirrhosis, Pharmacotherapy +22